As of 1st January 2023, the journal will have new Editors-in-Chief, Prof Liz Gardiner (Canberra, Australia) and Dr Will Parker (Sheffield, UK). The current editors are Steve Watson and Paul Harrison.
Dr William Parker is National Institute of Health & Care Research Clinical Lecturer in Cardiology at the University of Sheffield, UK. He qualified in Medicine and Pharmacology from the University of Cambridge before completing Foundation and Core Medical Training in his home city of Sheffield. He completed six years as a research fellow under the supervision of Professor Rob Storey at the University of Sheffield, training in laboratory techniques and clinical trial design relating to antiplatelet pharmacology. This included a 3-year British Heart Foundation Clinical Training Research Fellowship leading to the award of a PhD. He was appointed Clinical Lecturer in January 2022 and has been a Principal Editor of Platelets since January 2021.
His research interests and publications span the field of atherothrombosis but center on the dose-dependent effects of aspirin on the thrombotic and inflammatory responses. This includes the ongoing ‘WILLOW’ programme of clinical drug trials seeking to explore and optimize combination antithrombotic regimens for aspirin-treated patients with high-risk coronary syndromes. Distinctions have included a high commendation from the International Aspirin Foundation in 2021 and ranking as the top candidate in the UK during cardiology clinical training applications.
Professor Elizabeth Gardiner is the Deputy Director of the John Curtin School of Medical Research at the Australian National University, Canberra, Australia. She received her PhD in Biochemistry from Monash University (1994) and completed a postdoctoral fellowship supported by the American Heart Association at the Cleveland Clinic Foundation, Cleveland OH USA. She is Scientific Director of the National Platelet Referral and Research Centreat ANU and The Canberra Hospital. She has published 168 peer-reviewed research papers, commentaries and reviews in the area of platelet biochemistry and platelet receptor function, particularly relevant to both thrombosis and bleeding in patients. She identified a novel mechanism for shedding of vascular receptors triggered by shear stress, enabling new capabilities in diagnostic and therapeutic reagent development.
She is a Trustee of the Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ), Senior Associate Editor of Arteriosclerosis, Thrombosis and Vascular Biology, and on the Editorial Board of Blood. She is Treasurer of the National Association of Research Fellows (NARF). She was 2021 Chair of the American Society of Hematology (ASH) Scientific Committee on Platelets and Megakaryocytes and co-Chair of the International Society for Thrombosis and Haemostasis Biorheology Scientific Subcommittee. She is on the ISTH Membership Committee and the ISTH Basic Science Taskforce.